Rankings
▼
Calendar
RMD Q3 2024 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
Q3 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$1.2B
+7.2% YoY
Gross Profit
$682M
56.9% margin
Operating Income
$375M
31.3% margin
Net Income
$300M
25.1% margin
EPS (Diluted)
$2.04
QoQ Revenue Growth
+2.9%
Cash Flow
Operating Cash Flow
$402M
Free Cash Flow
$379M
Stock-Based Comp.
$20M
Balance Sheet
Total Assets
$6.8B
Total Liabilities
$2.2B
Stockholders' Equity
$4.6B
Cash & Equivalents
$238M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.2B
$1.1B
+7.2%
Gross Profit
$682M
$618M
+10.3%
Operating Income
$375M
$301M
+24.6%
Net Income
$300M
$233M
+29.2%
Revenue Segments
Sleep And Respiratory
$1.0B
88%
Software As Service
$148M
12%
Geographic Segments
Us Canada And Latin America
$687M
57%
Combined Europe Asia And Other Markets
$362M
30%
Sleep And Respiratory
$148M
12%
← FY 2024
All Quarters
Q4 2024 →